Avalair Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Montelukast

Indications/Uses

Prophylaxis & chronic treatment of asthma in adults & ped patients ≥12 mth. Symptomatic relief of day- & nighttime seasonal allergic rhinitis in adults & ped patients ≥2 yr.

Click to view Avalair detailed prescribing information

Dosage/Direction for Use

Adult ≥15 yr 2 chewable tab daily in the evening. Ped 2-5 yr One 4-mg chewable tab daily in the evening, 6-14 yr One 5-mg chewable tab daily in the evening.

Click to view Avalair detailed prescribing information

Overdosage

View Avalair overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

Click to view Avalair detailed prescribing information

Special Precautions

Not to be used for acute asthma attacks. Not to be abruptly substituted for inhaled or oral corticosteroids. Neuropsychiatric events. Avoid aspirin or NSAIDs in patients w/ known aspirin sensitivity. Monitor patients during systemic corticosteroid dose reduction. Unsuitable for phenylketonurics. May affect ability to drive & use machines. Pregnancy & lactation. Not to be given in childn <2 yr.

Click to view Avalair detailed prescribing information

Use In Pregnancy & Lactation

Click to view Avalair detailed prescribing information

Adverse Reactions

Palpitations, allergic granulomatosis angiitis; angioedema, bruising, erythema nodosum, atopic dermatitis, eczema, skin &/or subcutaneous tissue infection, rash, urticaria; GI, neurologic & psychiatric effects; blood coagulation disorder; raised ALT/AST levels, cholestatic hepatitis; hypersensitivity reactions; conjunctivitis, myopia; otalgia, otitis, otitis media; pyuria; bronchitis, acute cough, epistaxis, laryngitis, nasal congestion & discharge, pharyngitis, pneumonia, resp tract infection, rhinitis, sinusitis, upper resp infection, wheezing; arthralgia, myalgia; fatigue, fever, flu, malaise, traumatic injury; thrombocytopenia; obsessive-compulsive symptoms.

Drug Interactions

Elevated plasma conc w/ gemfibrozil. Severe peripheral edema w/ prednisone. Increased repaglinide plasma conc. Decreased bioavailability w/ phenobarb, rifampin. Concomitant use w/ CYP3A4 inducers eg, phenytoin, phenobarb, rifampicin.

Click to view Avalair detailed prescribing information

Storage

View Avalair storage conditions for details to ensure optimal shelf-life.

Description

View Avalair description for details of the chemical structure and excipients (inactive components).

Action

View Avalair mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations / Antihistamines & Antiallergics

ATC Classification

R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

Avalair chewable tab 4 mg

Packing/Price

4 × 7's

Form

Avalair chewable tab 5 mg

Packing/Price

4 × 7's

Avalair

montelukast

Manufacturer:

Nano Medic Care

Distributor:

Apex